Abstract

An account of the biomedical background of the initiative for the European light ion cancer therapy facility is given. Recent advances of the feasibility study of the superconducting separated sector cyclotron concept are presented, and alternative concepts of the facility design are discussed. It has been shown that the superconducting separated sector cyclotron, while fulfilling the basic requirements for the reference oxygen beam energy of 400 MeV/n and extracted beam intensity of 10/sup 12/ p.p.s., can lead to a compact, cost-effective, and technically feasible design. It is pointed out, however, that other technical solutions (e.g. synchrotrons and compact superconducting cyclotrons) need to be considered and their relative merits evaluated. >

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.